top of page
TILs - Case Studies
Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges
Zhao Y, Deng J, Rao S, Guo S, Shen J, Du F, Wu X, Chen Y, Li M, Chen M, Li X, Li W, Gu L, Sun Y, Zhang Z, Wen Q, Xiao Z, Li J.
Cancers (Basel). 2022 Aug 27;14(17):4160
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma
Maartje W. Rohaan, M.D., et al.
N Engl J Med 2022; 387:2113-2125
"In patients with advanced melanoma, progression-free survival was significantly longer among those who received TIL therapy than among those who received ipilimumab"
Publications - cell therapy: Files
Tumor Organoids - Case Studies
Tumor organoids: applications in cancer modeling and potentials in precision medicine
Xu, H., Jiao, D., Liu, A.
J Hematol Oncol 15, 58 (2022).
Patient-Derived Organoids for Precision Cancer Immunotherapy
M. Grönholm, M. Feodoroff, G. Antignani, B. Martins, F. Hamdan, V. Cerullo
Cancer Res (2021) 81 (12): 3149–3155
Publications - cell therapy: Files
bottom of page